Bikash Verma

512 total citations
16 papers, 426 citations indexed

About

Bikash Verma is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Bikash Verma has authored 16 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Bikash Verma's work include Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (8 papers) and Influenza Virus Research Studies (3 papers). Bikash Verma is often cited by papers focused on Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (8 papers) and Influenza Virus Research Studies (3 papers). Bikash Verma collaborates with scholars based in United States, Belgium and Italy. Bikash Verma's co-authors include Donna Catalano, Gyöngyi Szabó, Frédéric Lehmann, Caroline Lonez, Marco L. Davila, David A. Sallman, Jason Brayer, David E. Gilham, Piero Olliaro and C.P. Thakur and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Bikash Verma

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bikash Verma United States 11 160 140 121 84 71 16 426
Ana Flávia Popi Brazil 14 250 1.6× 39 0.3× 92 0.8× 89 1.1× 98 1.4× 25 440
Richard B. Sisson United States 5 394 2.5× 116 0.8× 65 0.5× 49 0.6× 96 1.4× 6 602
Éric Gaudreault Canada 11 266 1.7× 108 0.8× 122 1.0× 79 0.9× 92 1.3× 11 467
Seon-Ju Yeo South Korea 11 296 1.9× 50 0.4× 91 0.8× 44 0.5× 132 1.9× 14 520
Timothy J. Break United States 14 307 1.9× 70 0.5× 176 1.5× 19 0.2× 104 1.5× 23 593
Yongsheng Ma United States 8 76 0.5× 34 0.2× 96 0.8× 155 1.8× 206 2.9× 10 578
Chelsea Gerada Australia 4 142 0.9× 44 0.3× 124 1.0× 28 0.3× 116 1.6× 6 380
Caitlyn L. Holmes United States 12 147 0.9× 33 0.2× 70 0.6× 23 0.3× 112 1.6× 18 453
Denise V. R. Bullen Australia 8 96 0.6× 69 0.5× 158 1.3× 199 2.4× 52 0.7× 9 369
Angeline Tilly Dang United States 9 95 0.6× 59 0.4× 79 0.7× 54 0.6× 141 2.0× 10 347

Countries citing papers authored by Bikash Verma

Since Specialization
Citations

This map shows the geographic impact of Bikash Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bikash Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bikash Verma more than expected).

Fields of papers citing papers by Bikash Verma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bikash Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bikash Verma. The network helps show where Bikash Verma may publish in the future.

Co-authorship network of co-authors of Bikash Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Bikash Verma. A scholar is included among the top collaborators of Bikash Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bikash Verma. Bikash Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Frey, Sharon E., Sepehr Shakib, Pornthep Chanthavanich, et al.. (2019). Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly. Open Forum Infectious Diseases. 6(4). ofz107–ofz107. 11 indexed citations
3.
4.
Lonez, Caroline, Alain Hendlisz, Philippe Aftimos, et al.. (2018). Celyad's novel CAR T-cell therapy for solid malignancies. Current Research in Translational Medicine. 66(2). 53–56. 19 indexed citations
5.
Sallman, David A., Jason Brayer, Elizabeth M. Sagatys, et al.. (2018). NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient. Haematologica. 103(9). e424–e426. 63 indexed citations
6.
7.
Sallman, David A., Tessa Kerre, Xavier Poiré, et al.. (2018). Remissions in Relapse/Refractory Acute Myeloid Leukemia Patients Following Treatment with NKG2D CAR-T Therapy without a Prior Preconditioning Chemotherapy. Blood. 132(Supplement 1). 902–902. 20 indexed citations
8.
Sallman, David A., Jason Brayer, Xavier Poiré, et al.. (2018). Abstract CT129: The THINK clinical trial: Preliminary evidence of clinical activity of NKG2D chimeric antigen receptor T cell therapy (CYAD-01) in acute myeloid leukemia. Cancer Research. 78(13_Supplement). CT129–CT129. 7 indexed citations
9.
10.
11.
Verma, Bikash, Philippe Aftimos, Ahmad Awada, et al.. (2017). A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types.. Journal of Clinical Oncology. 35(15_suppl). TPS3093–TPS3093. 4 indexed citations
12.
Block, Stan L., Bikash Verma, Fang Xie, et al.. (2015). Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination. Vaccine. 33(18). 2175–2182. 16 indexed citations
13.
Szabó, Gyöngyi, et al.. (1994). Acute ethanol consumption synergizes with trauma to increase monocyte tumor necrosis factor ? production late postinjury. Journal of Clinical Immunology. 14(6). 340–352. 34 indexed citations
14.
Szabó, Gyöngyi, et al.. (1994). Regulatory Potential of Ethanol and Retinoic Acid on Human Monocyte Functions. Alcoholism Clinical and Experimental Research. 18(3). 548–554. 21 indexed citations
15.
Szabó, Gyöngyi, Bikash Verma, & Donna Catalano. (1993). Selective inhibition of antigen-specific T lymphocyte proliferation by acute ethanol exposure: the role of impaired monocyte antigen presentation capacity and mediator production. Journal of Leukocyte Biology. 54(6). 534–544. 80 indexed citations
16.
Thakur, C.P., et al.. (1992). Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 86(6). 615–616. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Flávia Popi Breakdown of academic impact, for papers by Richard B. Sisson Breakdown of academic impact, for papers by Éric Gaudreault Breakdown of academic impact, for papers by Seon-Ju Yeo Breakdown of academic impact, for papers by Timothy J. Break Breakdown of academic impact, for papers by Yongsheng Ma Breakdown of academic impact, for papers by Chelsea Gerada Breakdown of academic impact, for papers by Caitlyn L. Holmes Breakdown of academic impact, for papers by Denise V. R. Bullen Breakdown of academic impact, for papers by Angeline Tilly Dang
Rankless by CCL
2026